FISK1: A Study on the Possible Health Effects of Lean Fish, Fatty Fish and Lean Meat Intake in Non-obese Adults

Sponsor
University of Bergen (Other)
Overall Status
Completed
CT.gov ID
NCT02130908
Collaborator
Bergen Medical Research Foundation (Other), Skretting ASA (Other), Leroy Seafood Group ASA (Industry)
45
1
3
52
0.9

Study Details

Study Description

Brief Summary

This study is a pilot study to investigate whether intake of lean or fatty fish, or lean meat would affect parameters related to health in healthy non-obese adults, and will serve as basis for future calculation of group sizes in coming studies. Participants consumed 750g/week of fillets of fish or meat for 4 weeks.

Hypothesis:

High intake of either lean or fatty fish will not affect serum concentrations of lipids and inflammatory markers as well as improve glucose tolerance during the 4 week intervention period when compared to lean meat intake.

Condition or Disease Intervention/Treatment Phase
  • Other: Lean fish
  • Other: Fatty fish
  • Other: Lean meat
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
45 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Other
Study Start Date :
Mar 1, 2011
Actual Primary Completion Date :
Jul 1, 2015
Actual Study Completion Date :
Jul 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Lean fish

Other: Lean fish
Participants consumed 150g of lean fish, five times per week for 4 weeks

Experimental: Fatty fish

Other: Fatty fish
Participants consumed 150g of fatty fish, five times per week for 4 weeks

Experimental: Lean meat

Other: Lean meat
Participants consumed 150g of lean meat, five times per week for 4 weeks

Outcome Measures

Primary Outcome Measures

  1. Changes in metabolic parameters (lipids, glucose, inflammatory markers) measured in serum [Endpoint after 4 weeks intervention]

Secondary Outcome Measures

  1. Changes in body weight [Endpoint after 4 weeks intervention]

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 35 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • adults

  • non-obese

  • healthy

Exclusion Criteria:
  • diabetes

  • diagnosed diseases of the intestine or cardiovacular system

Contacts and Locations

Locations

Site City State Country Postal Code
1 Haukeland University Hospital Bergen Norway 5021

Sponsors and Collaborators

  • University of Bergen
  • Bergen Medical Research Foundation
  • Skretting ASA
  • Leroy Seafood Group ASA

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Oddrun Anita Gudbrandsen, Researcher, University of Bergen
ClinicalTrials.gov Identifier:
NCT02130908
Other Study ID Numbers:
  • REK2011/572
First Posted:
May 6, 2014
Last Update Posted:
May 2, 2018
Last Verified:
May 1, 2018
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 2, 2018